Back to Awarded Treatment Trials
Awarded Trial: 00-130
Grant ID
00-130
Illness
Psychosis (children and adolescents)
Primary Drug/Intervention
Risperidone
Primary Dosage
N/A
Secondary Drug Intervention
Olanzapine
Secondary Dosage
N/A
Other Drug/Intervention
Haloperidol
Other Dosage
N/A
Status
Completed
Investigator
Sikich
Sample Size
38
Duration of Study Period for Each Subject
Approximately 3 years
Outcome Measurements
Treatment emergent side effects, adherence rates, frequency of relapse
Results
One participant developed involuntary movements of the face. Subjects gained about 35 pounds on average and one subject developed diabetes. About 16% of participants were non-compliant. There were no apparent differences between drugs with regard to relapse; on average there was about 1 re-hospitalization per subject.
Publication
N/A
Link
N/A
PI Name
Linmarie Sikich
Degree
MD
Center
Department of Psychiatry
Institution
University of North Carolina - Chapel Hill
Address
CB 7160
City or Town
Chapel Hill
State or Province
NC
Zip or Postal Code
27599
Country
USA
Email Address
lsikich@med.unc.edu